These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32410986)

  • 21. Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells.
    Pan J; Xu Y; Song H; Zhou X; Yao Z; Ji G
    BMC Complement Altern Med; 2017 Nov; 17(1):506. PubMed ID: 29183322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progress on anti-alcoholic gastric injury active components and mechanisms of Chinese herbal medicine].
    Xue-Xue W; Ai-Wu Y; Zhu-Ping T; Ying LI; Can-Wei LI; Meng-Ran F; Wei-Hong L; Peng-Fei G
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4836-4845. PubMed ID: 33350254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review.
    Zhu M; Sun Y; Bai H; Wang Y; Yang B; Wang Q; Kuang H
    Front Pharmacol; 2023; 14():1159985. PubMed ID: 37063281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of colitis-associated colorectal cancer with 8-hydroxydeoxyguanosine.
    Ock CY; Kim EH; Hong H; Hong KS; Han YM; Choi KS; Hahm KB; Chung MH
    Cancer Prev Res (Phila); 2011 Sep; 4(9):1507-21. PubMed ID: 21733838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chang-wei-qing, a Chinese herbal formula, ameliorates colitis-associated tumour development via inhibiting NF-κB and STAT3 signalling pathway.
    Wan G; Xie M; Zhang X; Li M
    Pharm Biol; 2019 Dec; 57(1):231-237. PubMed ID: 30905249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
    Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
    Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress in active compounds effective on ulcerative colitis from Chinese medicines.
    Cao SY; Ye SJ; Wang WW; Wang B; Zhang T; Pu YQ
    Chin J Nat Med; 2019 Feb; 17(2):81-102. PubMed ID: 30797423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
    Li J; Su X; Dai L; Chen N; Fang C; Dong Z; Fu J; Yu Y; Wang W; Zhang H; Wang H; Ji Y; Liu Y; Cheng L; Shi G; Zhang S; Yang Y; Deng H
    Carcinogenesis; 2020 Apr; 41(2):235-244. PubMed ID: 31802101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer.
    Li L; Leung PS
    Int J Biochem Cell Biol; 2014 Aug; 53():224-36. PubMed ID: 24875648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herbal medicines for the prevention of alcoholic liver disease: a review.
    Ding RB; Tian K; Huang LL; He CW; Jiang Y; Wang YT; Wan JB
    J Ethnopharmacol; 2012 Dec; 144(3):457-65. PubMed ID: 23058988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling.
    Kim YH; Kim JH; Kim BG; Lee KL; Kim JW; Koh SJ
    J Gastroenterol Hepatol; 2019 Mar; 34(3):544-551. PubMed ID: 30378164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
    Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
    Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
    [No Abstract]   [Full Text] [Related]  

  • 33. Herbal Medicines Targeting the Improved
    Wickramasinghe ASD; Kalansuriya P; Attanayake AP
    Evid Based Complement Alternat Med; 2021; 2021():2920530. PubMed ID: 34335803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
    Sakurai T; Higashitsuji H; Kashida H; Watanabe T; Komeda Y; Nagai T; Hagiwara S; Kitano M; Nishida N; Abe T; Kiyonari H; Itoh K; Fujita J; Kudo M
    Oncotarget; 2017 Apr; 8(15):24762-24776. PubMed ID: 28160571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
    Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
    Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
    Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
    Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
    Xie L; Jiang FC; Zhang LM; He WT; Liu JH; Li MQ; Zhang X; Xing S; Guo H; Zhou P
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.
    Kavitha K; Kowshik J; Kishore TK; Baba AB; Nagini S
    Biochim Biophys Acta; 2013 Oct; 1830(10):4433-44. PubMed ID: 23726989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis Triggering, an Important Way for Natural Products From Herbal Medicines to Treat Pancreatic Cancers.
    Li M; Tang D; Yang T; Qian D; Xu R
    Front Pharmacol; 2021; 12():796300. PubMed ID: 35222011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses.
    Hayakawa Y; Hirata Y; Nakagawa H; Sakamoto K; Hikiba Y; Otsuka M; Ijichi H; Ikenoue T; Tateishi K; Akanuma M; Ogura K; Yoshida H; Ichijo H; Omata M; Maeda S
    Gastroenterology; 2010 Mar; 138(3):1055-67.e1-4. PubMed ID: 19931259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.